Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum]
Omboni S, Malacco E, Mallion JM, Volpe M. Clinical Interventions in Aging. 2015;10:1575–1586.On page 1584, left column, 4th row from the bottom, the age indicated should be 65–69 rather than 65–59.Read the original article
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-08-01
|
| Series: | Clinical Interventions in Aging |
| Online Access: | https://www.dovepress.com/corrigendum-olmesartan-vs-ramipril-in-the-treatment-of-hypertensi-peer-reviewed-article-CIA |